Olanzapin 1a Pharma (Olanzapine)

Olanzapine, the active ingredient in Olanzapin 1a Pharma, is an atypical antipsychotic presented as a 10 mg tablet for oral use. It treats schizophrenia and bipolar I disorder in adults and adolescents when other therapies are insufficient.

GNH USA supplies Olanzapin 1a Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olanzapine acts as a dopamine‑serotonin antagonist for several psychiatric conditions. - Schizophrenia: reduces positive and negative symptoms and helps prevent relapse. - Bipolar I disorder (manic phase): stabilises mood and decreases the frequency of manic episodes. - Schizoaffective disorder: alleviates psychotic features and mood disturbances. - Major depressive disorder with psychotic features: augments the antidepressant response. - Maintenance therapy: supports long‑term symptom control after acute stabilization.

Olanzapine may cause a range of adverse reactions, from mild to potentially serious.

Common Side Effects: - Weight gain: often noticeable within weeks of therapy. - Sedation: drowsiness or feeling of fatigue. - Dry mouth: reduced salivation. - Constipation: slowed gastrointestinal motility. - Elevated triglycerides: increase in blood lipid levels. - Orthostatic hypotension: drop in blood pressure upon standing.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: high fever, muscle rigidity, autonomic instability. - Hyperglycaemia and new‑onset diabetes mellitus. - Seizures: especially in patients with a history of epilepsy. - Tardive dyskinesia: involuntary, repetitive movements. - Agranulocytosis: severe reduction in white‑blood cell count. - Hepatotoxicity: liver enzyme elevations. - Severe allergic reactions: rash, swelling, anaphylaxis.

When prescribing olanzapine, clinicians should consider several safety aspects. - Metabolic monitoring: regularly check weight, fasting glucose and lipid profile. - Cardiovascular assessment: evaluate blood pressure and heart rate, especially at treatment start. - CNS effects: advise patients about sedation and avoid operating heavy machinery. - Pregnancy and lactation: use only if benefits outweigh risks and discuss with obstetric care. - Drug‑interaction review: assess concomitant medications for additive CNS depression. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Olenzol  

Major Interactions (Avoid): -   -   -  g  t 

---

t \\